Friday, DUSA Pharmaceuticals Inc. (DUSA) said its third-quarter GAAP net loss narrowed to $0.4 million or $0.02 per share from $2.8 million or $0.12 per share in the prior year period.
Non-GAAP net loss for the quarter, was $0.2 million or $0.01 per share narrower than $1.6 million or $0.07 per common share in the year-ago period.
Product revenues for the quarter rose to $6.93 million from $5.72 million in the comparable period.
For comments and feedback: editorial@rttnews.com